The operator of the BR2 research reactor in Belgium is considering whether to postpone planned experiments in order to create additional capacity for the production of crucial medical radioisotopes.
The operator of the BR2 unit, Belgian nuclear research centre SCK CEN, said it has already decided to extend its operating cycle to cope with any shortage of radioisotopes.
The move follows a technical failure that prevented the startup of the high-flux research reactor (HFR) at Petten in the Netherlands, a facility that also produces radioisotopes.
The operator of the BR2 unit, Belgian nuclear research centre SCK CEN, said it has already decided to extend its operating cycle to cope with any shortage of radioisotopes.
The move follows a technical failure that prevented the startup of the high-flux research reactor (HFR) at Petten in the Netherlands, a facility that also produces radioisotopes.
Want to keep reading?
Register free and get full access to NucNet for 14 days. No card required.
- Daily news briefing on the global nuclear industry
- Weekly, monthly and topical newsletters
- 24/7 coverage during nuclear incidents and safety events
- Full searchable archive, 30,000+ articles since 1991
- SMR and AMR project database
- Analysis, Focus pieces and infographics
- NucNet Style Guide for nuclear reporters and communicators
After the trial, keep a free account for a newsletter and a complimentary Plus article every two weeks. Or see our subscription plans for individuals and organisations.
See subscription options
